Faringel Plus

Faringel Plus is a multi-ingredient oral suspension formulated for the protection of the gastroesophageal and oral mucosa. It is a complex preparation containing sodium alginate, hyaluronic acid, propolis, honey, and botanical extracts including aloe vera, calendula, and chamomile. The product is primarily used to manage symptoms of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR), where sodium alginate forms a physical barrier to prevent the regurgitation of gastric contents while carbonates neutralize stomach acid. Additionally, the hyaluronic acid and propolis components provide re-epithelializing, anti-inflammatory, and antimicrobial benefits that facilitate tissue repair in the oral cavity and esophagus. This makes Faringel Plus particularly effective for treating oral mucositis and esophagitis, including cases induced by radiotherapy or chemotherapy in oncology and palliative care settings. It is developed by the Italian company Ca. Di. Group and is generally marketed as a nutraceutical or medical device in Europe.

Brand names

Faringel Plus

Other names

Faringel Plus suspensionFaringel+